NeuroPace (NPCE) Accumulated Expenses (2020 - 2026)

NeuroPace has reported Accumulated Expenses for 7 years, with the latest figure at $9.3 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 15.96% year-over-year to $9.3 million; the trailing twelve-month figure through Mar 2026 stood at $9.3 million (up 15.96% YoY), and the FY2025 full-year result was $13.3 million, up 36.29% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $9.3 million, down from $13.3 million in the prior quarter.
• The five-year high for Accumulated Expenses was $13.3 million in Q4 2025, with the low at $6.6 million in Q1 2023.
• Average Accumulated Expenses over 5 years is $9.0 million, with a median of $8.2 million recorded in 2023.
• Year-over-year, Accumulated Expenses jumped 87.73% in 2022 and dropped 12.46% in 2024.
• Tracing NPCE's Accumulated Expenses over 5 years: stood at $7.4 million in 2022, then soared by 50.8% to $11.2 million in 2023, then declined by 12.46% to $9.8 million in 2024, then jumped by 36.29% to $13.3 million in 2025, then fell by 29.95% to $9.3 million in 2026.
• The last three Accumulated Expenses figures came in at $9.3 million (Q1 2026), $13.3 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.

Peer Comparison